美国FDA网站于2014年4月17日发布了“FDA warns against morcellation in hysterectomy,myomectomy”的警示,由此而在世界范围内引起不小的震动。由于对该事件的了解和相关专业知识的认识差异,不同作者的观点有不同的倾向,从而在不同的医生和普通大众中间产生了不同的结论和观点。因此,有必要对此警示进行深入地分析和诠释。一、FDA警示的真正含义FDA的警示实质上是对肿瘤分碎技术使用的警示,并不是禁止使用该技术。因而,FDA建议 On April 17, 2014, the FDA website issued a warning on the “FDA warns against morcellation in hysterectomy, myomectomy,” which caused quite a stir in the world. Different viewpoints of different authors have different tendencies due to their different understanding of the event and related professional knowledge, thus resulting in different conclusions and opinions among different doctors and the general public. Therefore, it is necessary to conduct an in-depth analysis and interpretation of this warning. First, the true meaning of the FDA warning FDA’s warning is essentially a warning of the use of tumor fragmentation technology, not to prohibit the use of the technology. Therefore, the FDA recommends